NCT06130891

Brief Summary

The goal of this clinical trial is to compare the effects of cognitive sensory motor relearning, and sensory-motor relearning program alone on manual ability, sensation, gross and fine movements, and cognition in post-stroke patients. The main aim is to evaluate the effectiveness of an integrated approach and its impact on motor function, sensory processing, and cognitive skills in sub-acute stroke patients, with the goal of contributing to the development of more efficient rehabilitation interventions for UL sensory-motor impairments after stroke.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Nov 2023

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 5, 2023

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

November 9, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 14, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2024

Completed
Last Updated

May 7, 2024

Status Verified

May 1, 2024

Enrollment Period

5 months

First QC Date

November 9, 2023

Last Update Submit

May 6, 2024

Conditions

Keywords

cognitive exercise therapysensory motor relearningupper limb function

Outcome Measures

Primary Outcomes (4)

  • Action Research Arm Test

    Changes from baseline The instrument contains 19 items grouped into 4 sub-tests: grasp, grip, pinch, and gross motor. Item performance is rated on a 4-point scale (0=unable; 1=partial; 2= abnormal; 3=normal) then item ratings are summed and reported out of 57 points with higher score indicating greater UE function.

    6 weeks

  • Revised Nottingham Sensory Assessment (Somatosensory Impairments)

    Changes from baseline rNSA examines somatosensory impairment using a 3-point scale (0 =absent, 1 = impaired, 2 = normal) and takes approximately 25-35 min to complete. It consists of 72 items grouped into three sub-scales measuring tactile sensation, proprioception, and stereognosis. The Tactile Sensation subscale includes light touch, temperature, pinprick, pressure, tactile localization, and bilateral simultaneous touch. Higher scores demonstrate better somatosensory function.

    6 weeks

  • ABILHAND questionnaire (ABIL)

    Changes from baseline ABILHAND is an inventory of 23 manual activities that the patient is originally asked to judge on a 3-level scale: 0 (impossible), 1 (difficult), and 2 (easy). The test explores bi-manual activities done without other human or technical help. For each question the patient provided his/her feeling of difficulty irrespective of the limb(s) actually used to do the activity. Activities not attempted in the last 3 months are not scored and encoded as missing responses.

    6 weeks

  • MoCA (Montreal Cognitive Assessment)

    Changes from baseline Montreal Cognitive Assessment (MoCA) is a one-page, 30-point cognitive screening measurement scale that takes about 10 minutes to administer. There are 12 subtasks in the MoCA test that include memory, visuospatial orientation, executive functioning, phonemic fluency, and two-item abstract thinking task, attention, concentration, and working memory, language, orientation to time and place. A score of 26 is a cutoff score to differentiate between normal and abnormal.

    6 weeks

Study Arms (3)

Cognitive sensory motor relearning Group

EXPERIMENTAL

Cognitive, sensory, and motor training

Other: Cognitive sensory motor relearning

Sensory Motor Relearning Group

EXPERIMENTAL

Sensory and motor training

Other: Sensory motor relearning

Motor Relearning Group

EXPERIMENTAL

Motor training

Other: Motor Relearning

Interventions

Cognitive Exercises: * Orientation: Checking awareness of date, time, and weather. * Attention: Tasks like connecting dots or spotting differences. * Shape Sorting: Sorting objects by size, color, etc. * Calculation Training: Counting money, beads, basic arithmetic. * Memory: Recalling objects on a tray, numbers backward, word associations. Sensory Relearning: * Discrimination: Identifying textures, shapes, sizes, and temperatures. * Tactile Recognition: Recognizing objects through touch. * Proprioception: Matching affected limb's position to unaffected limb's. Motor Relearning: * Task-Specific Training: Grasping, pouring, wiping, screwing, holding objects. * Progression: Increasing duration, intensity, and resistance. 45 minutes per day, 5 days a week for 6 weeks.

Cognitive sensory motor relearning Group

Sensory Relearning: * Discrimination: Identifying textures, shapes, sizes, and temperatures. * Tactile Recognition: Recognizing objects through touch. * Proprioception: Matching affected limb's position to unaffected limb's. Motor Relearning: * Task-Specific Training: Grasping, pouring, wiping, screwing, holding objects. * Progression: Increasing duration, intensity, and resistance. 45 minutes per day, 5 days a week for 6 weeks.

Sensory Motor Relearning Group

Motor Relearning: * Task-Specific Training: Grasping, pouring, wiping, screwing, holding objects. * Progression: Increasing duration, intensity, and resistance. 45 minutes per day, 5 days a week for 6 weeks.

Motor Relearning Group

Eligibility Criteria

Age45 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Both male and female patients.
  • years of age.
  • st ever stroke.
  • Sub-acute ischemic stroke.
  • weeks post stroke patients.
  • Participants must have motor and somatosensory deficits in the upper limb on the affected side, as indicated by an ARAT score between 40 and 50 out of 57.
  • Participants must be able to provide informed consent or have a legal representative who can provide informed consent on their behalf.
  • MoCA score between 18-24
  • Modified Ashworth scale \< +1

You may not qualify if:

  • Participants who have a history of significant neurological or psychiatric disorders, other than stroke, that could interfere with upper limb motor or sensory recovery.
  • Participants who have other medical conditions that could interfere with therapy or assessments, such as severe arthritis or joint injuries.
  • Participants who have severe visual or hearing impairments that would interfere with therapy or assessments.
  • Participants who are currently participating in another clinical trial or research study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

THQ Hospital, Muridke, Sheikhupura, Punjab

Sheikhupura, Punjab Province, 39000, Pakistan

Location

MeSH Terms

Conditions

StrokeIschemia

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Aruba Saeed, PhD

    Riphah International University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 9, 2023

First Posted

November 14, 2023

Study Start

November 5, 2023

Primary Completion

March 30, 2024

Study Completion

March 30, 2024

Last Updated

May 7, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations